What are the metabolic pathways of phenylalanine and tyrosine?

Metabolic Pathways of Phenylalanine and Tyrosine

Primary Pathway: Phenylalanine to Tyrosine Conversion

The central metabolic pathway involves the hepatic enzyme phenylalanine hydroxylase (PAH) converting phenylalanine to tyrosine, with tetrahydrobiopterin (BH4) serving as an essential cofactor 1. This reaction occurs exclusively in hepatic and renal tissues and represents the rate-limiting step in phenylalanine metabolism 2.

Key Enzymatic Steps:

• Phenylalanine → Tyrosine: Catalyzed by PAH with BH4 cofactor
• Normal serum phenylalanine: ~60 μmol/L
• This conversion is the sole mechanism for tyrosine production from dietary phenylalanine in mammals 1

Downstream Tyrosine Catabolism Pathway

Once tyrosine is formed, it undergoes sequential enzymatic degradation 3:

Sequential Enzymatic Steps:

1. Tyrosine → 4-hydroxyphenylpyruvate: Via tyrosine aminotransferase (TAT)
2. 4-hydroxyphenylpyruvate → Homogentisic acid: Via 4-hydroxyphenylpyruvate dioxygenase (HPD)
3. Homogentisic acid → Maleylacetoacetate: Via homogentisate dioxygenase (HGD)
4. Maleylacetoacetate → Fumarylacetoacetate: Via maleylacetoacetate isomerase (MAI)
5. Fumarylacetoacetate → Fumarate + Acetoacetate: Via fumarylacetoacetate hydrolase (FAH)

The final products (fumarate and acetoacetate) enter the citric acid cycle and ketone body metabolism, respectively 3.

Critical Metabolic Branch Points

Tyrosine-Derived Metabolites:

Beyond catabolism, tyrosine serves as precursor for 1:

• Melanin (pigment synthesis)
• Dopamine (neurotransmitter)
• Norepinephrine (catecholamine)
• Epinephrine (catecholamine)

Blood-Brain Barrier Transport:

Phenylalanine competes with other large neutral amino acids (LNAAs) for transport across the blood-brain barrier 4. Elevated phenylalanine levels competitively inhibit transport of tyrosine, tryptophan, and other LNAAs, disrupting neurotransmitter synthesis in the central nervous system.

Cofactor Pathway: Tetrahydrobiopterin (BH4)

BH4 synthesis and regeneration is essential for PAH activity 2. Defects in this pathway cause secondary PAH deficiency:

BH4 Metabolism Enzymes:

• GTP cyclohydrolase (synthesis)
• 6-pyruvoyl-tetrahydrobiopterin synthetase (synthesis)
• Dihydropteridine reductase (regeneration)
• Pterin carbinolamine-4α-dehydratase (regeneration)

Alternative Pathways in Plants

While not directly relevant to human metabolism, plants possess an alternative phenylpyruvate pathway for phenylalanine synthesis via cytosolic tyrosine:phenylpyruvate aminotransferase 5, 6. This microbial-like pathway interconnects tyrosine catabolism with phenylalanine synthesis in plant systems.

Clinical Significance of Pathway Disruption

PAH Deficiency (Phenylketonuria):

• Phenylalanine accumulates (>1,200 μmol/L in classical PKU) 2
• Tyrosine becomes conditionally essential
• Reduced dopamine, norepinephrine synthesis 1, 7
• Neurotoxicity from elevated phenylalanine and metabolites

Tyrosinemia Type I:

• FAH deficiency causes accumulation of fumarylacetoacetate and maleylacetoacetate 3
• Toxic metabolites: succinylacetone (inhibits heme synthesis), succinylacetoacetate
• Clinical manifestations: hepatic damage, renal Fanconi syndrome, porphyric crises
• NTBC therapy blocks pathway at HPD, preventing toxic metabolite formation but elevates tyrosine

Interconnected Metabolic Networks

The phenylalanine-tyrosine pathway connects to 4, 8:

• Protein synthesis (both amino acids are proteogenic)
• Neurotransmitter synthesis (dopaminergic, noradrenergic pathways)
• Energy metabolism (via fumarate entering TCA cycle)
• Ketone body metabolism (via acetoacetate)
• Heme synthesis (inhibited by succinylacetone in tyrosinemia)

Gut Microbiota Contribution:

Gut bacteria metabolize aromatic amino acids through alternative pathways, producing nine circulating metabolites that affect intestinal permeability and systemic immunity 8, 9. This includes production of phenylpyruvate, indole derivatives, and other aromatic metabolites.

Regulatory Mechanisms

Allosteric regulation occurs at three key enzymes 6:

1. Chorismate mutase (phenylalanine/tyrosine synthesis in plants)
2. Tryptophan synthase (tryptophan biosynthesis)
3. Arogenate dehydratase (phenylalanine biosynthesis)

In mammals, PAH activity is primarily regulated by substrate availability and BH4 cofactor levels, with feedback mechanisms involving tyrosine concentrations affecting dopamine synthesis 7.